CeftazidiMe hydrate
Modify Date: 2024-01-14 12:13:58
CeftazidiMe hydrate structure
|
Common Name | CeftazidiMe hydrate | ||
|---|---|---|---|---|
| CAS Number | 120618-65-7 | Molecular Weight | 564.59 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H24N6O8S2 | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
| Symbol |
GHS08 |
Signal Word | Danger | |
| Name | CeftazidiMe hydrate |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C22H24N6O8S2 |
|---|---|
| Molecular Weight | 564.59 |
| Appearance of Characters | solid |
| Storage condition | 2-8°C |
| Water Solubility | 0.1 M NaOH: soluble50mg/mL |
| Symbol |
GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H317-H319-H334 |
| Precautionary Statements | P261-P280-P305 + P351 + P338-P342 + P311 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn |
| Risk Phrases | 42/43 |
| Safety Phrases | 22-36/37-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Analyte induced water adsorbability in gas phase biosensors: the influence of ethinylestradiol on the water binding protein capacity.
Analyst 140(9) , 3225-32, (2015) An ultra-sensitive gas phase biosensor/tracer/bio-sniffer is an emerging technology platform designed to provide real-time information on air-borne analytes, or those in liquids, through classical hea... |
|
|
Antibiotics and renal branching morphogenesis: comparison of toxicities.
Pediatr. Res. 76(6) , 508-14, (2014) Many premature born neonates receive antibiotic drugs to treat infections, which are applied during active nephrogenesis. We studied the impact of clinical concentrations of gentamicin and alternative... |
|
|
Biodegradable drug-eluting nanofiber-enveloped implants for sustained release of high bactericidal concentrations of vancomycin and ceftazidime: in vitro and in vivo studies.
Int. J. Nanomedicine 9 , 4347-55, (2014) We developed biodegradable drug-eluting nanofiber-enveloped implants that provided sustained release of vancomycin and ceftazidime. To prepare the biodegradable nanofibrous membranes, poly(D,L)-lactid... |
| MFCD00153936 |